BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 36965898)

  • 1. A novel necroptosis-associated miRNA signature predicting prognosis of endometrial cancer and correlated with immune infiltration.
    Ye Z; Jiang Y; Wu J
    Taiwan J Obstet Gynecol; 2023 Mar; 62(2):291-298. PubMed ID: 36965898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.
    Zhang Q; Luo Y; Zhang S; Huang Q; Liu G
    Sci Rep; 2024 Feb; 14(1):4257. PubMed ID: 38383747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Defined Necroptosis-Related miRNAs Signature for Predicting the Prognosis of Colon Cancer.
    Yang Z; Lu S; Wang Y; Tang H; Wang B; Sun X; Qu J; Rao B
    Int J Gen Med; 2022; 15():555-565. PubMed ID: 35046713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer.
    Wu X; Han Y; Liu F; Ruan L
    J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
    Gene; 2019 May; 697():86-93. PubMed ID: 30779946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs.
    Yu Z; Lu C; Lu B; Gao H; Liang R; Xiang W
    BMC Genomics; 2023 Mar; 24(1):162. PubMed ID: 36991314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering a Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Clear Cell Renal Carcinoma.
    Bao JH; Li JB; Lin HS; Zhang WJ; Guo BY; Li JJ; Fu LM; Sun YP
    Anal Cell Pathol (Amst); 2022; 2022():2721005. PubMed ID: 35509814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel-Defined Necroptosis-Related miRNA Signature for Forecasting the Prognosis of Low-Grade Glioma.
    Lu Z; Wang C; Qu T; Feng Y
    Biomed Res Int; 2022; 2022():9957604. PubMed ID: 36199758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Necroptosis-Related Markers in Head and Neck Carcinoma by Bioinformatics.
    Zheng L; Li M; Gu R; Zhang H; Qi X; Dong H
    J Immunol Res; 2022; 2022():1993023. PubMed ID: 35785035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
    Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 3-miRNA signature predicts survival of patients with hypopharyngeal squamous cell carcinoma after post-operative radiotherapy.
    Xu X; Lu Z; Gross N; Li G; Zhang F; Lei D; Pan X
    J Cell Mol Med; 2019 Dec; 23(12):8280-8291. PubMed ID: 31578816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel necroptosis-associated miRNA signature for predicting the prognosis in head and neck squamous cell carcinoma.
    Guan J; Liu X; Wang K; Jia Y; Yang B
    Open Med (Wars); 2022; 17(1):1682-1698. PubMed ID: 36349193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma.
    Meng T; Wang Q; Yang Y; Ren Y; Shi Y
    Front Genet; 2022; 13():825261. PubMed ID: 35495130
    [No Abstract]   [Full Text] [Related]  

  • 18. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
    Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Necroptosis-Related miRNA Signature as a Potential Predictive Biomarker for Prognosis and Immune Status in Colon Adenocarcinoma.
    Ma X; Yang B; Dong H; Lin H; Wang W
    J Oncol; 2022; 2022():9413562. PubMed ID: 36065304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.